Vendor review
Huaian Hanyou Peptide reviews
Huaian Hanyou Peptide reviews from 75 independent lab tests (Retatrutide, BPC-157 and GHK-Cu): grade A, purity and fill accuracy. Is Huaian Hanyou Peptide legit? See what its vials showed.
What the lab tests show
75 tests on record, newest first. Scores are purity divided by ten.
| Date | Product | Purity | Quantity | Identity | Certificate |
|---|---|---|---|---|---|
| Oct 9, 2026 | Retatrutide | 10 mg | Fail | View | |
| Sep 30, 2026 | Ipamorelin | 98.1 % | 9.7 mg of 10 mg (-3 %) | Pass | View |
| Sep 24, 2026 | Tesamorelin | 99.9 % | 9.36 mg of 10 mg (-6 %) | Pass | View |
| Sep 24, 2026 | Retatrutide | 99.9 % | 9.65 mg of 10 mg (-3 %) | Pass | View |
| Aug 26, 2026 | Tirzepatide | 99.9 % | 51.9 mg of 50 mg (4 %) | Pass | View |
| Aug 13, 2026 | Retatrutide | 99.9 % | 28.3 mg of 30 mg (-6 %) | Pass | View |
| Aug 9, 2026 | GHK-Cu | 99.7 % | 53.8 mg of 50 mg (8 %) | Pass | View |
| Aug 6, 2026 | Retatrutide | 99.8 % | 23.2 mg of 20 mg (16 %) | Pass | View |
| Aug 5, 2026 | Retatrutide | 10 mg | Fail | View | |
| Aug 5, 2026 | Retatrutide | 99.9 % | 5.01 mg of 5 mg (0 %) | Pass | View |
| Aug 5, 2026 | Retatrutide | 10 mg | Fail | View | |
| Aug 3, 2026 | GHK-Cu | 99.9 % | 90.3 mg of 100 mg (-10 %) | Pass | View |
| Aug 3, 2026 | Retatrutide | 99.9 % | 18.2 mg of 20 mg (-9 %) | Pass | View |
| Aug 2, 2026 | Tesamorelin | 99.6 % | 11.9 mg of 10 mg (19 %) | Pass | View |
| Aug 2, 2026 | Tesamorelin | 99.7 % | 13.8 mg of 10 mg (38 %) | Pass | View |
| Jul 23, 2026 | BPC-157 | 99.9 % | 5.54 mg of 10 mg (-45 %) | Pass | View |
| Jul 21, 2026 | Tirzepatide | 99.9 % | 20.6 mg of 20 mg (3 %) | Pass | View |
| Jul 21, 2026 | Tirzepatide | 10 mg | Fail | View | |
| Jul 20, 2026 | Retatrutide | 10 mg | Fail | View | |
| Jul 17, 2026 | Retatrutide | 99.9 % | 11.4 mg of 10 mg (14 %) | Pass | View |
| Jul 17, 2026 | Retatrutide | 10 mg | Fail | View | |
| Jul 17, 2026 | MOTS-c | 98.1 % | 9.8 mg of 10 mg (-2 %) | Pass | View |
| Jul 13, 2026 | MOTS-c | 99.4 % | 11.4 mg of 10 mg (14 %) | Pass | View |
| Jul 13, 2026 | Retatrutide | 99.9 % | 21.6 mg of 20 mg (8 %) | Pass | View |
| Jul 1, 2026 | BPC-157 | 98.7 % | 8.74 mg of 10 mg (-13 %) | Pass | View |
| Jul 1, 2026 | MOTS-c | 40 mg | Fail | View | |
| Jul 1, 2026 | Retatrutide | 99.9 % | 22 mg of 20 mg (10 %) | Pass | View |
| Jun 24, 2026 | GHK-Cu | 99.9 % | 36.1 mg of 50 mg (-28 %) | Pass | View |
| Jun 24, 2026 | BPC-157 | 99.5 % | 8.88 mg of 10 mg (-11 %) | Pass | View |
| Jun 24, 2026 | Tesamorelin | 98.2 % | 17.8 mg of 20 mg (-11 %) | Pass | View |
| Jun 24, 2026 | Ipamorelin | 99.8 % | 9.56 mg of 10 mg (-4 %) | Pass | View |
| Jun 17, 2026 | BPC-157 | 98.3 % | 9.47 mg of 10 mg (-5 %) | Pass | View |
| Jun 17, 2026 | BPC-157 | 5 mg | Fail | View | |
| Jun 17, 2026 | TB-500 | 96.1 % | 4.42 mg of 5 mg (-12 %) | Pass | View |
| Jun 16, 2026 | GHK-Cu | 99.9 % | 40 mg of 50 mg (-20 %) | Pass | View |
| Jun 16, 2026 | GHK-Cu | 99.9 % | 49.7 mg of 50 mg (-1 %) | Pass | View |
| Jun 16, 2026 | Retatrutide | 99.9 % | 4.85 mg of 5 mg (-3 %) | Pass | View |
| Jun 16, 2026 | Retatrutide | 94.3 % | 13.6 mg of 15 mg (-9 %) | Pass | View |
| Jun 16, 2026 | Retatrutide | 99.9 % | 18.5 mg of 20 mg (-8 %) | Pass | View |
| Jun 16, 2026 | Tirzepatide | 99.9 % | 28.4 mg of 30 mg (-5 %) | Pass | View |
| Jun 12, 2026 | Retatrutide | 99.9 % | 28.5 mg of 30 mg (-5 %) | Pass | View |
| Jun 2, 2026 | Retatrutide | 99.8 % | 22.9 mg of 20 mg (15 %) | Pass | View |
| Jun 2, 2026 | Retatrutide | 99.9 % | 13.9 mg of 15 mg (-7 %) | Pass | View |
| May 27, 2026 | MOTS-c | 99.5 % | 10.6 mg of 10 mg (6 %) | Pass | View |
| May 27, 2026 | Retatrutide | 99.9 % | 20.3 mg of 15 mg (35 %) | Pass | View |
| May 27, 2026 | MOTS-c | 99.4 % | 10.4 mg of 10 mg (4 %) | Pass | View |
| May 21, 2026 | Tesamorelin | 99.9 % | 9.64 mg of 10 mg (-4 %) | Pass | View |
| May 20, 2026 | Retatrutide | 99.9 % | 23.4 mg of 24 mg (-3 %) | Pass | View |
| May 13, 2026 | Tesamorelin | 99.9 % | 10.3 mg of 10 mg (3 %) | Pass | View |
| May 6, 2026 | Tesamorelin | 99.9 % | 4.22 mg of 10 mg (-58 %) | Pass | View |
| May 6, 2026 | Ipamorelin | 98.9 % | 7.25 mg of 10 mg (-28 %) | Pass | View |
| Apr 28, 2026 | Retatrutide | 99.9 % | 9.74 mg of 10 mg (-3 %) | Pass | View |
| Apr 28, 2026 | Retatrutide | 99.9 % | 14.7 mg of 15 mg (-2 %) | Pass | View |
| Apr 27, 2026 | Retatrutide | 99.8 % | 19.7 mg of 20 mg (-2 %) | Pass | View |
| Mar 29, 2026 | BPC-157 | 99.7 % | 5.2 mg of 10 mg (-48 %) | Pass | View |
| Mar 29, 2026 | TB-500 | 99.8 % | 3.7 mg of 10 mg (-63 %) | Pass | View |
| Mar 2, 2026 | Retatrutide | 99.8 % | 22.4 mg of 24 mg (-7 %) | Pass | View |
| Feb 20, 2026 | Tirzepatide | 99.9 % | 67.3 mg of 60 mg (12 %) | Pass | View |
| Feb 18, 2026 | GHK-Cu | 99.9 % | 84.1 mg of 100 mg (-16 %) | Pass | View |
| Feb 18, 2026 | Tirzepatide | 99.8 % | 23.7 mg of 20 mg (19 %) | Pass | View |
What Huaian Hanyou Peptide sells
No current listings on record.
About Huaian Hanyou Peptide
Finnrick has tested 75 samples from Huaian Hanyou Peptide across 8 products.